These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 3923823)

  • 1. Use of the agarose gel method to identify and quantitate factor VIII:C inhibitors.
    Cassidy PG; Triplett DA; LaDuca FM
    Am J Clin Pathol; 1985 Jun; 83(6):697-706. PubMed ID: 3923823
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A standardized method for measuring anti-F VIII: C inhibitors in haemophilia A by coagulation inhibition in agarose gel.
    Jorquera JI; Carmona E; Aznar JA; Peiró A; Sánchez-Cuenca JM
    Thromb Haemost; 1985 Aug; 54(2):377-80. PubMed ID: 3936211
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Agarose gel method: its usefulness in assaying factor VIII inhibitors, evaluating treatment and suggesting a mechanism of action for factor IX concentrates.
    Coots MC; Glueck HI; Miller MA
    Br J Haematol; 1985 Aug; 60(4):735-50. PubMed ID: 3927972
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Detection and Measurement of Factor Inhibitors.
    Kershaw G
    Methods Mol Biol; 2017; 1646():295-304. PubMed ID: 28804837
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Coagulation in an agarose gel and its application to the detection and measurement of factor VIII antibodies.
    Bird P
    Br J Haematol; 1975 Feb; 29(2):329-40. PubMed ID: 1191553
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nijmegen-Bethesda assay to measure factor VIII inhibitors.
    Duncan E; Collecutt M; Street A
    Methods Mol Biol; 2013; 992():321-33. PubMed ID: 23546724
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Laboratory identification of factor inhibitors: the perspective of a large tertiary hemophilia center.
    Kershaw G; Jayakodi D; Dunkley S
    Semin Thromb Hemost; 2009 Nov; 35(8):760-8. PubMed ID: 20169512
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In vitro detection of mild inhibitors to factor VIII in hemophilia.
    Ewing NP; Kasper CK
    Am J Clin Pathol; 1982 Jun; 77(6):749-52. PubMed ID: 6807080
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A method for detecting factor-VIII clotting activity associated with factor VIII-related antigen in agarose gels.
    Bird P; Rizza CR
    Br J Haematol; 1975 Sep; 31(1):5-12. PubMed ID: 1240008
    [TBL] [Abstract][Full Text] [Related]  

  • 10. An ELISA assay for the detection of factor VIII antibodies - comparison with the conventional Bethesda assay in a large cohort of haemophilia samples.
    Shetty S; Ghosh K; Mohanty D
    Acta Haematol; 2003; 109(1):18-22. PubMed ID: 12486318
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Detection of factor VIII inhibitors with the partial thromboplastin time.
    Lossing TS; Kasper CK; Feinstein DI
    Blood; 1977 May; 49(5):793-7. PubMed ID: 856360
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A detailed comparison of the performance of the standard versus the Nijmegen modification of the Bethesda assay in detecting factor VIII:C inhibitors in the haemophilia A population of Canada. Association of Hemophilia Centre Directors of Canada. Factor VIII/IX Subcommittee of Scientific and Standardization Committee of International Society on Thrombosis and Haemostasis.
    Giles AR; Verbruggen B; Rivard GE; Teitel J; Walker I
    Thromb Haemost; 1998 Apr; 79(4):872-5. PubMed ID: 9569207
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparative measurement of FVIII inhibitors in hemophilia A patients using ELISA and the Bethesda assay.
    Kim SY; Kang SY; Lee WI
    Korean J Lab Med; 2010 Jun; 30(3):260-3. PubMed ID: 20603586
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Factor VIII inhibitors: in vivo decrease of inhibitory activity during calcium infusion.
    Muhleman AF; Glueck HI; Miller MA; Coots M
    Am J Hematol; 1985 Oct; 20(2):107-17. PubMed ID: 3929595
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical patterns of hemophilic patients who develop inhibitors.
    McMillan CW
    Prog Clin Biol Res; 1984; 150():31-44. PubMed ID: 6431436
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Modification of the Bethesda assay for factor VIII or IX inhibitors to improve efficiency.
    Gadarowski JJ; Czapek EE; Ontiveros JD; Pedraza JL
    Acta Haematol; 1988; 80(3):134-8. PubMed ID: 3143212
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The Nijmegen modification of the Bethesda assay for factor VIII:C inhibitors: improved specificity and reliability.
    Verbruggen B; Novakova I; Wessels H; Boezeman J; van den Berg M; Mauser-Bunschoten E
    Thromb Haemost; 1995 Feb; 73(2):247-51. PubMed ID: 7792738
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Diagnostic and prognostic value of factor VIII binding antibodies in acquired hemophilia A: data from the GTH-AH 01/2010 study.
    Werwitzke S; Geisen U; Nowak-Göttl U; Eichler H; Stephan B; Scholz U; Holstein K; Klamroth R; Knöbl P; Huth-Kühne A; Bomke B; Tiede A
    J Thromb Haemost; 2016 May; 14(5):940-7. PubMed ID: 26988717
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Development of a new modified Bethesda method for coagulation inhibitors: the Osaka modified Bethesda method.
    Torita S; Suehisa E; Kawasaki T; Toku M; Takeo E; Tomiyama Y; Nishida S; Hidaka Y
    Blood Coagul Fibrinolysis; 2011 Apr; 22(3):185-9. PubMed ID: 21245748
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Modified Bethesda, modified Nijmegen and blank assays for coagulation factor VIII inhibitor detection and factors affecting the results].
    Feng HM; Li Q; Xu WS; Chen DM; Zheng L
    Nan Fang Yi Ke Da Xue Xue Bao; 2016 Apr; 36(4):592-5. PubMed ID: 27113194
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.